Who owns ARROWHEAD PHARMACEUTICALS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ARWR from SEC Form 13F filings across 487 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 487 institutions disclosed 117.6M shares of ARROWHEAD PHARMACEUTICALS, INC. worth $7.70B — about 83% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
487
13F holders
$7.70B
value, 2026 filers
83%
of shares outstanding (117.6M sh)
76
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ARWR's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 15.1M | $991.0M | 0.0% | 10.7% | +2.1% |
| 2 | Avoro Capital Advisors LLC | 11.0M | $720.0M | 7.4% | 7.8% | -3.1% |
| 3 | FMR LLC | 9.4M | $612.3M | 0.0% | 6.6% | +16.4% |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 6.2M | $406.5M | 0.0% | 4.4% | -2.2% |
| 5 | STATE STREET CORP | 6.1M | $400.7M | 0.0% | 4.3% | +7.5% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 6.1M | $400.5M | 0.0% | 4.3% | +0.1% |
| 7 | Vestal Point Capital, LP | 4.8M | $315.1M | 8.1% | 3.4% | +205.7% |
| 8 | Invesco Ltd. | 3.8M | $250.4M | 0.0% | 2.7% | -1.5% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 3.5M | $234.5M | 0.0% | 2.4% | -2.0% |
| 10 | FRED ALGER MANAGEMENT, LLC | 3.3M | $213.1M | 0.6% | 2.3% | -1.4% |
| 11 | Siren, L.L.C. | 2.3M | $149.9M | 3.5% | 1.6% | +33.5% |
| 12 | MORGAN STANLEY | 1.8M | $120.1M | 0.0% | 1.3% | +69.2% |
| 13 | BAKER BROS. ADVISORS LP | 1.7M | $111.9M | 0.5% | 1.2% | -14.2% |
| 14 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.5M | $95.1M | 0.0% | 1% | +57.2% |
| 15 | Janus Henderson Group Ltd.NEW | 1.3M | $88.2M | 0.0% | 1% | new |
| 16 | NORTHERN TRUST CORP | 1.2M | $76.6M | 0.0% | 0.8% | -1.9% |
| 17 | Hood River Capital Management LLC | 1.1M | $74.0M | 0.6% | 0.8% | +0.9% |
| 18 | TWO SIGMA INVESTMENTS, LP | 1.1M | $70.9M | 0.0% | 0.8% | +86.6% |
| 19 | DIMENSIONAL FUND ADVISORS LP | 1.1M | $70.0M | 0.0% | 0.8% | -9.5% |
| 20 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 954,744 | $62.5M | 0.0% | 0.7% | -1.0% |
| 21 | BANK OF AMERICA CORP /DE/ | 941,597 | $61.6M | 0.0% | 0.7% | -17.4% |
| 22 | VANGUARD FIDUCIARY TRUST CO | 902,211 | $59.0M | 0.0% | 0.6% | +0.6% |
| 23 | Fisher Asset Management, LLC | 893,700 | $58.5M | 0.0% | 0.6% | -6.7% |
| 24 | PRICE T ROWE ASSOCIATES INC /MD/ | 886,044 | $58.0M | 0.0% | 0.6% | +3.8% |
| 25 | GOLDMAN SACHS GROUP INC | 848,997 | $55.6M | 0.0% | 0.6% | -26.2% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.